Junyan Tao

3.4k total citations
79 papers, 2.1k citations indexed

About

Junyan Tao is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Junyan Tao has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 18 papers in Cell Biology and 14 papers in Cancer Research. Recurrent topics in Junyan Tao's work include Hippo pathway signaling and YAP/TAZ (16 papers), Wnt/β-catenin signaling in development and cancer (16 papers) and Cancer-related gene regulation (12 papers). Junyan Tao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (16 papers), Wnt/β-catenin signaling in development and cancer (16 papers) and Cancer-related gene regulation (12 papers). Junyan Tao collaborates with scholars based in China, United States and Germany. Junyan Tao's co-authors include Satdarshan P. Monga, Xin Chen, Lei Zhao, Ji-Hua Dong, Sucha Singh, Diego F. Calvisi, Yuan-Jin Guo, Sarangarajan Ranganathan, Feng Jin and Ran Pang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Junyan Tao

74 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyan Tao China 28 1.2k 448 327 273 269 79 2.1k
Xiongying Miao China 31 1.0k 0.9× 475 1.1× 166 0.5× 666 2.4× 321 1.2× 114 2.6k
Chang Han United States 28 1.2k 1.0× 519 1.2× 96 0.3× 469 1.7× 203 0.8× 61 2.5k
Dae‐Ghon Kim South Korea 28 1.3k 1.1× 577 1.3× 147 0.4× 365 1.3× 207 0.8× 49 2.1k
Min Ma China 29 1.2k 1.0× 641 1.4× 98 0.3× 187 0.7× 79 0.3× 125 2.3k
Fan Feng China 26 945 0.8× 625 1.4× 105 0.3× 334 1.2× 197 0.7× 66 1.8k
Xiaoling Zhou China 24 909 0.8× 174 0.4× 191 0.6× 249 0.9× 165 0.6× 83 1.6k
Nan Wu China 30 1.5k 1.3× 915 2.0× 126 0.4× 265 1.0× 51 0.2× 90 2.6k
Claudia Bocca Italy 25 747 0.6× 345 0.8× 115 0.4× 197 0.7× 367 1.4× 59 1.8k
Ling Fang China 24 1.4k 1.2× 1.1k 2.4× 149 0.5× 238 0.9× 150 0.6× 65 2.3k
Antonina Azzolina Italy 28 916 0.8× 229 0.5× 93 0.3× 201 0.7× 155 0.6× 53 2.0k

Countries citing papers authored by Junyan Tao

Since Specialization
Citations

This map shows the geographic impact of Junyan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Tao more than expected).

Fields of papers citing papers by Junyan Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Tao. The network helps show where Junyan Tao may publish in the future.

Co-authorship network of co-authors of Junyan Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Junyan Tao. A scholar is included among the top collaborators of Junyan Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyan Tao. Junyan Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xuchen, et al.. (2025). Cytokine release syndrome complicated with sepsis induced by tislelizumab in a patient with advanced hepatocellular carcinoma: A case report. Human Vaccines & Immunotherapeutics. 21(1). 2597064–2597064.
3.
Lehrich, Brandon M., Junyan Tao, Silvia Liu, et al.. (2024). Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC. JHEP Reports. 6(12). 101186–101186. 11 indexed citations
4.
Zhou, Hai, et al.. (2023). Role of YES1 signaling in tumor therapy resistance. SHILAP Revista de lepidopterología. 2(3). 210–218. 5 indexed citations
5.
Sun, Dantong, Han Zhao, Hai Zhou, et al.. (2023). ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma. Translational Oncology. 33. 101685–101685. 3 indexed citations
6.
Tao, Junyan, et al.. (2022). Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of Apoptosis. American Journal Of Pathology. 193(2). 148–160. 3 indexed citations
7.
Jiang, Lili, Lifan Liang, Kelly Koral, et al.. (2021). The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma. American Journal Of Pathology. 191(7). 1180–1192. 32 indexed citations
8.
Liang, Lifan, Kunju Zhu, Junyan Tao, & Songjian Lu. (2021). ORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network. PLoS Computational Biology. 17(4). e1008792–e1008792. 1 indexed citations
9.
Delgado, Evan R., et al.. (2021). Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling. Molecular and Cellular Biology. 41(4). 12 indexed citations
10.
Yan, Xiumei, Jing Wang, Haixing Xu, et al.. (2021). PDLLA/β-TCP/HA/CHS/NGF Sustained-release Conduits for Peripheral Nerve Regeneration. Journal of Wuhan University of Technology-Mater Sci Ed. 36(4). 600–606. 6 indexed citations
11.
Wang, Haichuan, Raj Bandaru, Matthew A. Lawlor, et al.. (2021). Selective targeting of MYC mRNA by stabilized antisense oligonucleotides. Oncogene. 40(47). 6527–6539. 10 indexed citations
12.
Shu, Zhang, Jie Zhang, Katja Evert, et al.. (2020). The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans. American Journal Of Pathology. 190(7). 1397–1413. 11 indexed citations
13.
Gérard, Claude, Stefano Caruso, Gabrielle Couchy, et al.. (2019). Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma. Journal of Hepatology. 71(2). 323–332. 10 indexed citations
14.
Zhang, Jie, Liu Pin, Junyan Tao, et al.. (2019). TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. American Journal Of Pathology. 189(5). 1077–1090. 19 indexed citations
15.
Zhang, Shanshan, Jingxiao Wang, Haichuan Wang, et al.. (2018). Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans. American Journal Of Pathology. 188(4). 995–1006. 28 indexed citations
16.
Ganesh, Shanthi, Martin L. Koser, Junyan Tao, et al.. (2016). Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin. Molecular Cancer Therapeutics. 15(9). 2143–2154. 50 indexed citations
17.
Pang, Ran, Junyan Tao, Shuling Zhang, et al.. (2010). Ethanol Extract from Ampelopsis sinica Root Exerts Anti‐Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro. Evidence-based Complementary and Alternative Medicine. 2011(1). 939205–939205. 12 indexed citations
18.
Zhao, Lei, Junyan Tao, Zhang Shu-ling, et al.. (2008). Anti-inflammatory Mechanism ofRungia pectinata (Linn.) Nees. Immunopharmacology and Immunotoxicology. 30(1). 135–151. 10 indexed citations
19.
Zhang, Xiaoyu, Junyan Tao, Lei Zhao, et al.. (2007). In vitro anti-inflammatory effects of different solution fractions of ethanol extract from Melilotus suaveolens Ledeb. Chinese Medical Journal. 120(22). 1992–1998. 13 indexed citations
20.
Tao, Junyan, et al.. (2007). Growth Law of Gamma-linolenic Acid Production by Cunninghamella echinulata. 4(1). 55–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026